Semaglutide…
A Transformative Impact!

Accepting and treating weight gain (lipogenesis) as a disease is critical for patients. We can help with information on the science behind weight gain and tips on supporting your weight-management goals.

Semaglutide, the active ingredient in Ozempic, is a groundbreaking GLP-1 receptor agonist that effectively manages blood sugar levels and supports weight loss. This once-weekly injection mimics the natural hormone GLP-1, enhancing insulin secretion and promoting a feeling of fullness. With its dual benefits for both type 2 diabetes management and weight reduction, Semaglutide is a powerful tool for improving overall health and wellness. Embrace a new standard of care with Semaglutide and experience the transformative benefits it offers.

Semaglutide…
A Transformative Impact!

Accepting and treating weight gain (lipogenesis) as a disease is critical for patients. We can help with information on the science behind weight gain and tips on supporting your weight-management goals.

Semaglutide, the active ingredient in Ozempic, is a groundbreaking GLP-1 receptor agonist that effectively manages blood sugar levels and supports weight loss. This once-weekly injection mimics the natural hormone GLP-1, enhancing insulin secretion and promoting a feeling of fullness. With its dual benefits for both type 2 diabetes management and weight reduction, Semaglutide is a powerful tool for improving overall health and wellness. Embrace a new standard of care with Semaglutide and experience the transformative benefits it offers.

Medical Uses

Semaglutide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

The higher-dose formulation of semaglutide is indicated as an adjunct to diet and exercise for long-term weight management in adults with an (initial body mass index (BMI) ≥ 30 kg/m2) or who are overweight (initial BMI ≥ 27 kg/m2) and have at least one weight-related comorbidity.

In March 2024, the US Food and Drug Administration (FDA) expanded the indication for semaglutide, in combination with a reduced calorie diet and increased physical activity, to reduce the risk of cardiovascular death, heart attack and stroke in obese or overweight adults with cardiovascular disease.

Other Uses

Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. It can be administered by subcutaneous injection or taken orally.

It was approved for medical use in the US in 2017. In 2021, it was the 90th most commonly prescribed medication in the United States, with more than 8 million prescriptions.

Other Uses

Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. It can be administered by subcutaneous injection or taken orally.

It was approved for medical use in the US in 2017. In 2021, it was the 90th most commonly prescribed medication in the United States, with more than 8 million prescriptions.

Just Published in the New England Journal

“As part of a weight loss program, the use of semaglutide helped people with weight gain lose an average of 15% of their body weight during 68 weeks of treatment. This equated to an average of 34 pounds of weight loss during the trial”.

Food Noise

Semaglutide and similar drugs, such as dulaglutide and liraglutide, have been used to treat binge eating disorder (BED), as they can successfully minimize obsessive thoughts about food and binging urges. Some users of these drugs have reported significant reduction in what is colloquially known as “food noise” (constant, unstoppable thoughts about eating despite not being physically hungry), which can be a factor of BED.

Food Noise

Semaglutide and similar drugs, such as dulaglutide and liraglutide, have been used to treat binge eating disorder (BED), as they can successfully minimize obsessive thoughts about food and binging urges. Some users of these drugs have reported significant reduction in what is colloquially known as “food noise” (constant, unstoppable thoughts about eating despite not being physically hungry), which can be a factor of BED.

Mechanism of Action

Semaglutide is a glucagon-like peptide-1 receptor agonist. The drug decreases blood sugar levels. The decrease is theorized to be caused by the mimicking of the incretin glucagon-like peptide-1 (GLP-1). It also appears to enhance growth of pancreatic beta cells, which are responsible for insulin production and release. Additionally, it inhibits the production of glucagon, the hormone that increases glycogenolysis (release of stored carbohydrate from the liver) and gluconeogenesis (synthesis of new glucose). It reduces food intake by lowering appetite and slowing down digestion in the stomach, helping reduce body fat.

Achieve up to 30% weight loss

0%

Reach an A1C under 7% or lower

0%

Start Your Journey Today

GET STARTED

Semaglutide…
A Transformative Impact!

Semaglutide…
A Transformative Impact!

Medical Uses

Other Uses

Other Uses

Just Published in the New England Journal

Food Noise

Food Noise

Mechanism of Action

Achieve up to 30% weight loss

Reach an A1C under 7% or lower

Start Your Journey Today

MMRx Locations

LICENSES

CONTACT US

Semaglutide…A Transformative Impact!

Semaglutide…A Transformative Impact!

Medical Uses

Other Uses

Other Uses

Just Published in the New England Journal

Food Noise

Food Noise

Mechanism of Action

Achieve up to 30% weight loss

Reach an A1C under 7% or lower

Start Your Journey Today

MMRx Locations

LICENSES

CONTACT US

Semaglutide…
A Transformative Impact!

Semaglutide…
A Transformative Impact!